{"id":2894,"date":"2023-11-23T05:07:00","date_gmt":"2023-11-23T04:07:00","guid":{"rendered":"http:\/\/bioscom.onpressidium.com\/non-classifiee\/jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil\/"},"modified":"2025-10-02T12:14:46","modified_gmt":"2025-10-02T11:14:46","slug":"jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil","status":"publish","type":"post","link":"https:\/\/bioserenity.com\/fr\/non-classifiee\/jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil\/","title":{"rendered":"Jolt Capital investit dans BIOSerenity, un leader dans le domaine du diagnostic neurologique et des troubles du sommeil"},"content":{"rendered":"\n<ul class=\"wp-block-list\">\n<li>Cet investissement de 24 millions d&rsquo;euros permettra d&rsquo;acc\u00e9l\u00e9rer le d\u00e9veloppement international et le d\u00e9ploiement d&rsquo;une IA de pointe dans le domaine de la t\u00e9l\u00e9m\u00e9decine.<\/li>\n\n\n\n<li>Cette annonce est renforc\u00e9e par la nomination de Vincent Marcel en tant que CEO de BIOSerenity.<\/li>\n\n\n\n<li>Ce nouvel investissement est une nouvelle preuve des ambitions de Jolt Capital dans le domaine de la saisie et du traitement avanc\u00e9s des donn\u00e9es de sant\u00e9.<\/li>\n<\/ul>\n\n<p>Paris, 13 novembre 2023<\/p>\n\n<p>Jolt Capital, soci\u00e9t\u00e9 ind\u00e9pendante de capital-investissement sp\u00e9cialis\u00e9e dans l&rsquo;investissement de croissance dans les entreprises deeptech europ\u00e9ennes, investit 24 M\u20ac dans BIOSerenity, sp\u00e9cialiste des dispositifs m\u00e9dicaux connect\u00e9s et des services m\u00e9dicaux innovants en \u00e9lectrophysiologie.<\/p>\n\n<p><br\/>Gr\u00e2ce \u00e0 la pertinence de ses recherches, aux services qu&rsquo;elle a d\u00e9velopp\u00e9s et \u00e0 ses experts, BIOSerenity a su se diff\u00e9rencier et devenir une v\u00e9ritable r\u00e9f\u00e9rence sur son march\u00e9. Cet investissement cl\u00e9 pour Jolt Capital s&rsquo;inscrit dans sa strat\u00e9gie d&rsquo;acquisition d&rsquo;entreprises europ\u00e9ennes \u00e0 tr\u00e8s fort potentiel.<\/p>\n\n<p><br\/>Jean Schmitt, Managing Partner et Pr\u00e9sident de Jolt Capital, commente : \u00ab\u00a0La sant\u00e9 est l&rsquo;un des secteurs strat\u00e9giques qui doit b\u00e9n\u00e9ficier d&rsquo;une acc\u00e9l\u00e9ration des financements si l&rsquo;on veut voir \u00e9merger un leadership m\u00e9dical et industriel fran\u00e7ais. C&rsquo;est pourquoi nous sommes ravis d&rsquo;investir dans BIOSerenity, qui a cr\u00e9\u00e9 les meilleurs dispositifs m\u00e9dicaux et logiciels d&rsquo;IA du march\u00e9 pour l&rsquo;\u00e9lectroenc\u00e9phalographie. BIOSerenity est un exemple parfait de la th\u00e8se d&rsquo;investissement de Jolt Capital. Lorsqu&rsquo;une entreprise dispose d&rsquo;une base propri\u00e9taire de technologies de pointe \u00e9prouv\u00e9es sur le march\u00e9, sa capacit\u00e9 \u00e0 attirer des financements importants pour soutenir son d\u00e9veloppement reste intacte\u00a0\u00bb.<\/p>\n\n<p><br\/>Fond\u00e9e en 2014, BIOSerenity a con\u00e7u une gamme in\u00e9gal\u00e9e de dispositifs m\u00e9dicaux et de logiciels pour l&rsquo;\u00e9lectroenc\u00e9phalographie. L&rsquo;entreprise a \u00e9galement \u00e9tendu le champ d&rsquo;application de ses solutions innovantes \u00e0 d&rsquo;autres domaines, dont les troubles du sommeil. Aujourd&rsquo;hui, avec plus de 300 partenaires et 150 000 patients trait\u00e9s chaque ann\u00e9e, BIOSerenity est devenu un leader dans le domaine du diagnostic neurologique et des troubles du sommeil.<\/p>\n\n<p><br\/><em>\u00a0\u00bb Alors que nous entamons la prochaine phase de notre d\u00e9veloppement, nous sommes ravis de b\u00e9n\u00e9ficier de la recapitalisation de Jolt Capital suite \u00e0 la r\u00e9cente crise de croissance \u00a0\u00bb commentent Pierre-Yves Frouin, Fondateur, et Samir Medjebar, Directeur G\u00e9n\u00e9ral Services en France. \u00a0\u00bb En moins de 10 ans, notre technologie a aid\u00e9 plus d&rsquo;un million de patients et nous avons \u00e9t\u00e9 le fer de lance de l&rsquo;innovation dans les domaines de la neurologie ambulatoire, du sommeil et de l&rsquo;IA m\u00e9dicale. Cette nouvelle \u00e9tape nous permettra d&rsquo;offrir notre technologie \u00e0 un plus grand nombre de patients et de continuer \u00e0 innover\u00a0\u00bb.<\/em><\/p>\n\n<p>L&rsquo;investissement de 24 millions d&rsquo;euros de Jolt Capital permettra \u00e0 la soci\u00e9t\u00e9 d&rsquo;acc\u00e9l\u00e9rer le d\u00e9veloppement international de ses activit\u00e9s en s&rsquo;appuyant sur ses deux principaux march\u00e9s, la France et les Etats-Unis, et en se concentrant sur l&rsquo;Europe. Le financement sera \u00e9galement utilis\u00e9 pour d\u00e9ployer une intelligence artificielle encore plus puissante afin d&rsquo;aider les m\u00e9decins dans leurs diagnostics. Enfin, l&rsquo;\u00e9quipe de direction de l&rsquo;entreprise sera renforc\u00e9e afin d&rsquo;assurer le d\u00e9veloppement de BIOSerenity.<\/p>\n\n<p><br\/>Vincent Marcel a \u00e9t\u00e9 nomm\u00e9 CEO de la soci\u00e9t\u00e9 : <em>\u00ab\u00a0Je suis impressionn\u00e9 par la combinaison unique de technologies de rupture que BIOSerenity a d\u00e9velopp\u00e9e dans le domaine de la neurologie et de services innovants de prise en charge des patients. Je suis impatient de diriger la prochaine \u00e9tape de d\u00e9veloppement, en m&rsquo;appuyant sur mon exp\u00e9rience dans les services de sant\u00e9 et sur l&rsquo;engagement fort de Jolt Capital. Avec les \u00e9quipes de BIOSerenity, nous allons acc\u00e9l\u00e9rer en Europe et aux Etats-Unis pour apporter une m\u00e9decine personnalis\u00e9e, pr\u00e9ventive et rentable sur<br\/>pour les troubles neurologiques et du sommeil.\u00a0\u00bb<\/em><\/p>\n\n<p><strong>A propos de Jolt Capital<a href=\"https:\/\/www.jolt-capital.com\">(https:\/\/www.jolt-capital.com<\/a> )<\/strong><br\/>Jolt Capital est une soci\u00e9t\u00e9 ind\u00e9pendante de capital-investissement sp\u00e9cialis\u00e9e dans l&rsquo;investissement de croissance dans<br\/>les entreprises deeptech, avec pour mission de construire les futurs leaders europ\u00e9ens \u00e0 vocation mondiale.<br\/>Depuis 2011, Jolt Capital investit dans des entreprises B2B europ\u00e9ennes dont le chiffre d&rsquo;affaires est compris entre 10M\u20ac<br\/>et 50M\u20ac. L&rsquo;\u00e9quipe de Jolt Capita est compos\u00e9e uniquement d&rsquo;investisseurs et de gestionnaires exp\u00e9riment\u00e9s d&rsquo;entreprises de haute technologie<br\/>. Sa plateforme d&rsquo;IA propri\u00e9taire, Jolt.Ninja, permet un sourcing enrichi,<br\/>une due diligence acc\u00e9l\u00e9r\u00e9e et une d\u00e9tection automatique des cibles d&rsquo;investissement ou d&rsquo;acquisition.<br\/>Jolt Capital est situ\u00e9 \u00e0 Paris, Lausanne, Copenhague et Milan.<\/p>\n\n<h2 class=\"wp-block-heading\">Contact presse<\/h2>\n\n<p><br\/><strong>Contact g\u00e9n\u00e9ral avec les m\u00e9dias (Steele&amp;Holt)<br\/><\/strong><a href=\"mailto:jolt@steeleandholt.com\">jolt@steeleandholt.com<\/a><br\/>+33 6 33 73 85 16<br\/><\/p>\n\n<p><strong>Pour en savoir plus sur Jolt Capital :<\/strong><br\/>Philippe Perez (Responsable Marketing)<br\/><a href=\"mailto:philippe.perez@jolt-capital.com\">philippe.perez@jolt-capital.com <\/a><br\/>+33 6 23 82 67 19<\/p>\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Paris, 13 novembre 2023 Jolt Capital, soci\u00e9t\u00e9 ind\u00e9pendante de capital-investissement sp\u00e9cialis\u00e9e dans l&rsquo;investissement de croissance dans les entreprises deeptech europ\u00e9ennes, investit 24 M\u20ac dans BIOSerenity, sp\u00e9cialiste des dispositifs m\u00e9dicaux connect\u00e9s et des services m\u00e9dicaux innovants en \u00e9lectrophysiologie. Gr\u00e2ce \u00e0 la pertinence de ses recherches, aux services qu&rsquo;elle a d\u00e9velopp\u00e9s et \u00e0 ses experts, BIOSerenity a [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12],"tags":[],"class_list":["post-2894","post","type-post","status-publish","format-standard","hentry","category-non-classifiee"],"blocksy_meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.4 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Jolt Capital investit dans BIOSerenity, un leader dans le domaine du diagnostic neurologique et des troubles du sommeil - BioSerenity<\/title>\n<meta name=\"description\" content=\"Jolt Capital investit dans BIOSerenity, un leader dans le domaine du diagnostic neurologique et des troubles du sommeil - BioSerenity\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bioserenity.com\/fr\/non-classifiee\/jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Jolt Capital investit dans BIOSerenity, un leader dans le domaine du diagnostic neurologique et des troubles du sommeil\" \/>\n<meta property=\"og:description\" content=\"Jolt Capital investit dans BIOSerenity, un leader dans le domaine du diagnostic neurologique et des troubles du sommeil - BioSerenity\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bioserenity.com\/fr\/non-classifiee\/jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil\/\" \/>\n<meta property=\"og:site_name\" content=\"BioSerenity\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-23T04:07:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-02T11:14:46+00:00\" \/>\n<meta name=\"author\" content=\"Sylvain Lecomte\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sylvain Lecomte\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/bioserenity.com\\\/fr\\\/non-classifiee\\\/jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bioserenity.com\\\/fr\\\/non-classifiee\\\/jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil\\\/\"},\"author\":{\"name\":\"Sylvain Lecomte\",\"@id\":\"https:\\\/\\\/bioserenity.com\\\/fr\\\/#\\\/schema\\\/person\\\/fc43c0173c3fc71ade14b790e981104c\"},\"headline\":\"Jolt Capital investit dans BIOSerenity, un leader dans le domaine du diagnostic neurologique et des troubles du sommeil\",\"datePublished\":\"2023-11-23T04:07:00+00:00\",\"dateModified\":\"2025-10-02T11:14:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/bioserenity.com\\\/fr\\\/non-classifiee\\\/jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil\\\/\"},\"wordCount\":845,\"publisher\":{\"@id\":\"https:\\\/\\\/bioserenity.com\\\/fr\\\/#organization\"},\"articleSection\":[\"Non classifi\u00e9(e)\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/bioserenity.com\\\/fr\\\/non-classifiee\\\/jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil\\\/\",\"url\":\"https:\\\/\\\/bioserenity.com\\\/fr\\\/non-classifiee\\\/jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil\\\/\",\"name\":\"Jolt Capital investit dans BIOSerenity, un leader dans le domaine du diagnostic neurologique et des troubles du sommeil - BioSerenity\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bioserenity.com\\\/fr\\\/#website\"},\"datePublished\":\"2023-11-23T04:07:00+00:00\",\"dateModified\":\"2025-10-02T11:14:46+00:00\",\"description\":\"Jolt Capital investit dans BIOSerenity, un leader dans le domaine du diagnostic neurologique et des troubles du sommeil - BioSerenity\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/bioserenity.com\\\/fr\\\/non-classifiee\\\/jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/bioserenity.com\\\/fr\\\/non-classifiee\\\/jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/bioserenity.com\\\/fr\\\/non-classifiee\\\/jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/bioserenity.com\\\/fr\\\/accueil\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Jolt Capital investit dans BIOSerenity, un leader dans le domaine du diagnostic neurologique et des troubles du sommeil\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/bioserenity.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/bioserenity.com\\\/fr\\\/\",\"name\":\"BioSerenity\",\"description\":\"Connected &amp; Integrated Neurosciences. Brain monitoring &amp; remote diagnostic\",\"publisher\":{\"@id\":\"https:\\\/\\\/bioserenity.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/bioserenity.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/bioserenity.com\\\/fr\\\/#organization\",\"name\":\"BioSerenity\",\"url\":\"https:\\\/\\\/bioserenity.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/bioserenity.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/bioserenity.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/logo_bioserenity_BORDEAUX-600-o.png\",\"contentUrl\":\"https:\\\/\\\/bioserenity.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/logo_bioserenity_BORDEAUX-600-o.png\",\"width\":600,\"height\":170,\"caption\":\"BioSerenity\"},\"image\":{\"@id\":\"https:\\\/\\\/bioserenity.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/bioserenity\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@bioserenity9854\"],\"description\":\"BIOSerenity, founded in 2014, is the French leader in electrophysiological diagnostics, performing more than 45,000 EEGs (electroencephalograms), 8,000 PSGs (polysomnographies), and 5,000 ECGs (electrocardiograms) each year. Its offering combines medical devices, a software platform, and AI algorithms, all designed and produced in France, integrated into an ecosystem of services for the benefit of physicians and patients. This unique end-to-end solution enables complex examinations to be performed and provides remote interpretation of signals in a timely manner, contributing to faster and more reliable clinical decisions. As an expert in neurology, BIOSerenity has developed the Large Brain Model (LBM), a foundation model trained on more than ten years of EEG recordings. This database and AI platform give rise to decision support tools that improve the quality and speed of interpretation. Among its flagship services, the long-term (72-hour) home EEG, unique in France, speeds up access to diagnosis when hospital slots are hardly available. In sleep medicine, BIOSerenity relies on a network of dedicated centers and specialized medical and paramedical teams to accelerate the diagnosis of sleep disorders and optimize patient referral. This vertical integration - devices, software, AI, and medical services - supports continuous improvement in the care pathway, as well as faster and more reliable diagnosis.\",\"email\":\"contact@bioserenity.com\",\"legalName\":\"BIOSERENITY\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"201\",\"maxValue\":\"500\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/bioserenity.com\\\/fr\\\/#\\\/schema\\\/person\\\/fc43c0173c3fc71ade14b790e981104c\",\"name\":\"Sylvain Lecomte\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/15d873becb6ed43dcbf50673374fd97635f144e64ba90b182ce965b32aed43e3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/15d873becb6ed43dcbf50673374fd97635f144e64ba90b182ce965b32aed43e3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/15d873becb6ed43dcbf50673374fd97635f144e64ba90b182ce965b32aed43e3?s=96&d=mm&r=g\",\"caption\":\"Sylvain Lecomte\"},\"url\":\"https:\\\/\\\/bioserenity.com\\\/fr\\\/author\\\/sylvain-lecomte\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Jolt Capital investit dans BIOSerenity, un leader dans le domaine du diagnostic neurologique et des troubles du sommeil - BioSerenity","description":"Jolt Capital investit dans BIOSerenity, un leader dans le domaine du diagnostic neurologique et des troubles du sommeil - BioSerenity","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bioserenity.com\/fr\/non-classifiee\/jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil\/","og_locale":"fr_FR","og_type":"article","og_title":"Jolt Capital investit dans BIOSerenity, un leader dans le domaine du diagnostic neurologique et des troubles du sommeil","og_description":"Jolt Capital investit dans BIOSerenity, un leader dans le domaine du diagnostic neurologique et des troubles du sommeil - BioSerenity","og_url":"https:\/\/bioserenity.com\/fr\/non-classifiee\/jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil\/","og_site_name":"BioSerenity","article_published_time":"2023-11-23T04:07:00+00:00","article_modified_time":"2025-10-02T11:14:46+00:00","author":"Sylvain Lecomte","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Sylvain Lecomte","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bioserenity.com\/fr\/non-classifiee\/jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil\/#article","isPartOf":{"@id":"https:\/\/bioserenity.com\/fr\/non-classifiee\/jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil\/"},"author":{"name":"Sylvain Lecomte","@id":"https:\/\/bioserenity.com\/fr\/#\/schema\/person\/fc43c0173c3fc71ade14b790e981104c"},"headline":"Jolt Capital investit dans BIOSerenity, un leader dans le domaine du diagnostic neurologique et des troubles du sommeil","datePublished":"2023-11-23T04:07:00+00:00","dateModified":"2025-10-02T11:14:46+00:00","mainEntityOfPage":{"@id":"https:\/\/bioserenity.com\/fr\/non-classifiee\/jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil\/"},"wordCount":845,"publisher":{"@id":"https:\/\/bioserenity.com\/fr\/#organization"},"articleSection":["Non classifi\u00e9(e)"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/bioserenity.com\/fr\/non-classifiee\/jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil\/","url":"https:\/\/bioserenity.com\/fr\/non-classifiee\/jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil\/","name":"Jolt Capital investit dans BIOSerenity, un leader dans le domaine du diagnostic neurologique et des troubles du sommeil - BioSerenity","isPartOf":{"@id":"https:\/\/bioserenity.com\/fr\/#website"},"datePublished":"2023-11-23T04:07:00+00:00","dateModified":"2025-10-02T11:14:46+00:00","description":"Jolt Capital investit dans BIOSerenity, un leader dans le domaine du diagnostic neurologique et des troubles du sommeil - BioSerenity","breadcrumb":{"@id":"https:\/\/bioserenity.com\/fr\/non-classifiee\/jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bioserenity.com\/fr\/non-classifiee\/jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bioserenity.com\/fr\/non-classifiee\/jolt-capital-investit-dans-bioserenity-un-leader-dans-le-domaine-des-diagnostics-neurologiques-et-des-troubles-du-sommeil\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bioserenity.com\/fr\/accueil\/"},{"@type":"ListItem","position":2,"name":"Jolt Capital investit dans BIOSerenity, un leader dans le domaine du diagnostic neurologique et des troubles du sommeil"}]},{"@type":"WebSite","@id":"https:\/\/bioserenity.com\/fr\/#website","url":"https:\/\/bioserenity.com\/fr\/","name":"BioSerenity","description":"Connected &amp; Integrated Neurosciences. Brain monitoring &amp; remote diagnostic","publisher":{"@id":"https:\/\/bioserenity.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bioserenity.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/bioserenity.com\/fr\/#organization","name":"BioSerenity","url":"https:\/\/bioserenity.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/bioserenity.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/bioserenity.com\/wp-content\/uploads\/2023\/05\/logo_bioserenity_BORDEAUX-600-o.png","contentUrl":"https:\/\/bioserenity.com\/wp-content\/uploads\/2023\/05\/logo_bioserenity_BORDEAUX-600-o.png","width":600,"height":170,"caption":"BioSerenity"},"image":{"@id":"https:\/\/bioserenity.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/bioserenity\/","https:\/\/www.youtube.com\/@bioserenity9854"],"description":"BIOSerenity, founded in 2014, is the French leader in electrophysiological diagnostics, performing more than 45,000 EEGs (electroencephalograms), 8,000 PSGs (polysomnographies), and 5,000 ECGs (electrocardiograms) each year. Its offering combines medical devices, a software platform, and AI algorithms, all designed and produced in France, integrated into an ecosystem of services for the benefit of physicians and patients. This unique end-to-end solution enables complex examinations to be performed and provides remote interpretation of signals in a timely manner, contributing to faster and more reliable clinical decisions. As an expert in neurology, BIOSerenity has developed the Large Brain Model (LBM), a foundation model trained on more than ten years of EEG recordings. This database and AI platform give rise to decision support tools that improve the quality and speed of interpretation. Among its flagship services, the long-term (72-hour) home EEG, unique in France, speeds up access to diagnosis when hospital slots are hardly available. In sleep medicine, BIOSerenity relies on a network of dedicated centers and specialized medical and paramedical teams to accelerate the diagnosis of sleep disorders and optimize patient referral. This vertical integration - devices, software, AI, and medical services - supports continuous improvement in the care pathway, as well as faster and more reliable diagnosis.","email":"contact@bioserenity.com","legalName":"BIOSERENITY","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"201","maxValue":"500"}},{"@type":"Person","@id":"https:\/\/bioserenity.com\/fr\/#\/schema\/person\/fc43c0173c3fc71ade14b790e981104c","name":"Sylvain Lecomte","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/15d873becb6ed43dcbf50673374fd97635f144e64ba90b182ce965b32aed43e3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/15d873becb6ed43dcbf50673374fd97635f144e64ba90b182ce965b32aed43e3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/15d873becb6ed43dcbf50673374fd97635f144e64ba90b182ce965b32aed43e3?s=96&d=mm&r=g","caption":"Sylvain Lecomte"},"url":"https:\/\/bioserenity.com\/fr\/author\/sylvain-lecomte\/"}]}},"_links":{"self":[{"href":"https:\/\/bioserenity.com\/fr\/wp-json\/wp\/v2\/posts\/2894","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bioserenity.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bioserenity.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bioserenity.com\/fr\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/bioserenity.com\/fr\/wp-json\/wp\/v2\/comments?post=2894"}],"version-history":[{"count":3,"href":"https:\/\/bioserenity.com\/fr\/wp-json\/wp\/v2\/posts\/2894\/revisions"}],"predecessor-version":[{"id":5942,"href":"https:\/\/bioserenity.com\/fr\/wp-json\/wp\/v2\/posts\/2894\/revisions\/5942"}],"wp:attachment":[{"href":"https:\/\/bioserenity.com\/fr\/wp-json\/wp\/v2\/media?parent=2894"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bioserenity.com\/fr\/wp-json\/wp\/v2\/categories?post=2894"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bioserenity.com\/fr\/wp-json\/wp\/v2\/tags?post=2894"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}